Chemosensitizing and nephroprotective effect of resveratrol in cisplatin –treated animals

Table 1 Effects of CIS and/or RSVL treatment on the therapeutic action of CIS in mice bearing Ehrlich ascites carcinoma cells

Treatment	Mean survival time(days)	45-day survivors
Control	17 ± 3.74	0/10
RSVL (25 mg/kg)	12 ± 5.95^b	0/10
CIS (5 mg/kg)	25 ± 12.13	2/10
CIS (5 mg/kg) + RSVL (25 mg/kg) (supplied simultaneously)	48 ± 15.03^a,b	6/10

Each data represents the mean ± S.D. of ten mice.
^aSignificantly different from control at P-value < 0.05. ^bSignificantly different from CIS at P-value < 0.05.

ISSN: 1475-2867